Curaleaf Holdings (CURLF) Payables (2019 - 2025)
Curaleaf Holdings (CURLF) posted quarterly Payables of $110.5 million for Q4 2025, down 38.93% year-on-year from $180.9 million in Q4 2024, and down 38.93% on a QoQ basis from $180.9 million in Q4 2024.
Curaleaf Holdings (CURLF) Payables (2019 - 2025) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Payables for 7 consecutive years, with $110.5 million the latest figure, recorded in Q4 2025.
- Quarterly Payables fell 38.93% year-over-year to $110.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $110.5 million (down 38.93% YoY) and the FY2025 annual result came in at $110.5 million, down 38.93% from the prior year.
- Payables retreated to $110.5 million in Q4 2025 per CURLF's latest filing, from $180.9 million in the prior quarter.
- Over the last five years, Payables for CURLF reached as high as $204.8 million in Q2 2024 and fell as low as $2.0 million in Q4 2021.
- A 5-year average of $98.5 million and a median of $69.9 million in 2022 frame the typical range for Payables.
- Annual changes were most pronounced in 2021 — Payables slumped 95.82% — and 2022, when it surged 6648.27%.
- Year by year, Payables stood at $2.0 million in 2021, then jumped by 6648.27% to $132.7 million in 2022, then slipped by 10.46% to $118.8 million in 2023, then jumped by 52.24% to $180.9 million in 2024, then plunged by 38.93% to $110.5 million in 2025.
- According to Business Quant data, Payables over the past three periods registered $110.5 million, $180.9 million, and $185.7 million for Q4 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 731.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 8.82 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 110.46 Mn |
| Dec 31, 2024 | 180.85 Mn |
| Sep 30, 2024 | 185.70 Mn |
| Jun 30, 2024 | 204.84 Mn |
| Dec 31, 2023 | 118.80 Mn |
| Sep 30, 2023 | 63.72 Mn |
| Jun 30, 2023 | 69.36 Mn |
| Dec 31, 2022 | 132.67 Mn |
| Mar 31, 2022 | 69.88 Mn |
| Dec 31, 2021 | 1.97 Mn |
| Sep 30, 2021 | 60.76 Mn |
| Jun 30, 2021 | 42.96 Mn |
| Mar 31, 2021 | 38.65 Mn |
| Dec 31, 2020 | 47.04 Mn |
| Sep 30, 2020 | 30.80 Mn |
| Dec 31, 2019 | 12.74 Mn |